Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Integrated Solution Detects Retained Surgical Sponges

By HospiMedica International staff writers
Posted on 30 Mar 2015
A next-generation radio frequency (RF) detection system incorporates essential compliance support functions and improved scanning coverage for multiple surgical specialties.

The RF Assure Detection System X is based on a new handheld, stationary scanning device, the ArQ•Sphere bi-nodal scanner, which leverages dual three-dimensional (3-D) scan fields to deliver motion-free scanning with overlapping scan fields, creating an optimal surgical sponge detection zone for positioning challenges specific to extremity, head, neck, spine, and other specialty procedures. More...
The system uses a reliable, low-energy RF signal specifically designed for the detection of misplaced surgical sponges through blood, dense tissue, and bone.

The system is controlled by a compliance-driven interface designed to provide operating room (OR) staff “real-time” feedback, improving accessibility and data visibility during the procedures, and automatically stores case and scan records for convenient review and compliance. Additional patient-centric benefits realized by the use of adjunct detection technology include reduction in incremental time under anesthesia, and the use of X-rays associated with rectifying sponge miscounts.

Complementary components are available for full OR coverage, which include the ConformPlus II Antenna Array Body Scanner, a one-touch scanning technology that detects retained sponges in the torso; and the Blair-Port Wand X, a handheld, motion-based scanning device for the detection of missing sponges in the surrounding OR environment. The RF Assure Detection System X is a product of RF Surgical Systems (Carlsbad, CA, USA).

“The premium digital patient safety platform of the RF Assure Detection System X represents our next generation in market-leading detection technology and innovation from RF Surgical,” said John Buhler, CEO of RF Surgical. “The integration of a workflow-complementary interface with surgical specialty scanning capabilities significantly advances our efforts to eliminate the risks associated with retained surgical sponges for improved OR patient safety.”

“The value of adjunct detection technology for the prevention of retained surgical sponges in assuring OR staff confidence and patient safety cannot be overstated,” said Stella Nelson, RN, co-author of the seminal clinical study of the efficacy of the system. “The thoughtful design and technological improvements in the new RF Assure Detection System X reflect the compliance support needs of OR staff, resulting in important work flow efficiencies.”

Related Links:

RF Surgical Systems



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.